MedPath
HSA Approval

AZIMAX-250 TABLET 250MG

SIN15065P

AZIMAX-250 TABLET 250MG

AZIMAX-250 TABLET 250MG

August 8, 2016

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01FA10

azithromycin

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Hovid Bhd

Active Ingredients

Azithromycin dihydrate 262.05mg eqv Azithromycin

250mg

Azithromycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AZIMAX-250 TABLET 250MG - HSA Approval | MedPath